Carlyle Group and SK Capital Partners increased their upfront offer to take over gene therapy maker bluebird bio, the ...

For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. | For ...

SK Group said Wednesday it has launched a special committee on data protection as part of its efforts to improve ...

Featured products made with ECOTRIA CLARO, a copolyester engineered for cosmetics containers Introduced CLARO-CR70-delivering ...

SK Group Chairman Chey Tae-won apologised on Wednesday for a massive data leak at South Korea's largest mobile carrier, SK ...

SK Telecom’s disastrous cyber breach has once again shone the spotlight on telco network securityBeyond systems from some of ...

Through its “AI Infrastructure Superhighway” and “AI Pyramid Strategy” initiatives, SK Telecom is investing heavily in AI ...

SK Telecom, one of South Korea’s largest telcos, reported an 11.1 percent year-on-year (YoY) increase in data center revenue, ...

Under the amended agreement, Bluebird ( NASDAQ: BLUE) holders can choose to get the original offer of $3 a share in cash plus ...

Bluebird Bio's shares rallied ahead of the bell after suitors Carlyle and SK Capital Partners amended their bid for the gene-therapy company to include an option for investors to take a cash offer ...

As BlueOval SK Battery Park readies for production, worker concerns over health and safety are mounting. The company denies ...

The South Korean chip maker's proposed $3.87 billion manufacturing campus in Indiana is still on track after the West ...